Iris Acq Corp (IRAA)

$6.43 +1.42 (28.34%)
Market Cap 45.90M
Revenue (ttm) 0.00
Net Income (ttm) -2.90M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 65,400
Avg Vol 3,756
Day's Range N/A - N/A
Shares Out 7.14M
Stochastic %K 14%
Beta 0.21
Analysts Strong Buy
Price Target N/A

Company Profile

Iris Acquisition Corp does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Tribe Capital Growth Corp I and changed its name to Iris Acquisition Corp in July 2022. The company was incorporated in 2020 and is based in George Town, Cayman Islands. Iris Acquisition Corp is a subsidiary of Iris Acquisition Holdings LL...

Industry: Shell Companies
Sector: Financial Services
Address:
Zephyr House, 3rd Floor 122 Mary Street PO Box 10085, George Town, Cayman Islands
Chowface
Chowface May. 9 at 12:05 PM
$IRAA its the climb
0 · Reply
Chowface
Chowface May. 8 at 5:19 PM
$IRAA is this the start!???
0 · Reply
mark3rd
mark3rd May. 8 at 4:50 PM
$IRAA perking up, bids
0 · Reply
Chief_Bull_Made_Bear
Chief_Bull_Made_Bear May. 8 at 3:20 PM
$IRAA Liminatus Pharma ($LIMN) just dropped a brand-new investor intro video and barely anyone's watching yet. They're developing cutting-edge immunotherapies targeting Claudin18.2+ solid tumors, an emerging biomarker that's already drawn billion-dollar deals from major pharma players like Astellas. What makes LIMN stand out? A low float, a clean SPAC merger, and a pipeline backed by the NIH — this isn’t your average penny biotech. Why this matters: Claudin18.2 is a red-hot target in gastric & pancreatic cancers NIH collaboration gives them serious scientific credibility Trading under the radar with minimal volume = early entry potential Low float + catalyst = possible sharp upside Check out their intro video (uploaded just yesterday): 📽️ https://www.youtube.com/watch?v=36NnT_HNtl0 And pipeline breakdown: 🔗 http://liminatuspharma.com/bbs/content.php?co_id=cancer I’m waiting for a move when volume picks up.
0 · Reply
Chief_Bull_Made_Bear
Chief_Bull_Made_Bear May. 8 at 3:16 PM
$IRAA changed tickers to ($LIMN) Liminatus Pharma ($LIMN) just dropped a brand-new investor intro video and barely anyone's watching yet. They're developing cutting-edge immunotherapies targeting Claudin18.2+ solid tumors, an emerging biomarker that's already drawn billion-dollar deals from major pharma players like Astellas. What makes LIMN stand out? A low float, a clean SPAC merger, and a pipeline backed by the NIH — this isn’t your average penny biotech. Why this matters: Claudin18.2 is a red-hot target in gastric & pancreatic cancers. NIH collaboration gives them serious scientific credibility. Trading under the radar with minimal volume = early entry potential. Low float + catalyst = possible sharp upside. Check out their intro video: 📽️ https://www.youtube.com/watch?v=36NnT_HNtl0 And pipeline breakdown: 🔗 http://liminatuspharma.com/bbs/content.php?co_id=cancer I’m watching for a move when volume picks up again. $TSLA $GME $SPY $BTC
0 · Reply
Chief_Bull_Made_Bear
Chief_Bull_Made_Bear May. 8 at 3:04 PM
$IRAA Volume brings massive swings here $BTC $TRUMP.X $DOGE.X
0 · Reply
Chief_Bull_Made_Bear
Chief_Bull_Made_Bear May. 8 at 12:08 AM
$IRAA changed ticker to $LIMN The free float for LIMN (Liminatus Pharma Inc.) is 174.48K shares. This means that out of the total 7.07M shares outstanding, only 174.48K are available for public trading. The remaining shares are likely held by insiders, promoters, or other restricted parties. A smaller free float can sometimes lead to higher price volatility, as fewer shares are available for trading, Already spiked 5 to 24 / 8 to 16 just fyi do whatever you wanna do. $TSLA $GME
0 · Reply
Chowface
Chowface May. 7 at 12:20 PM
$IRAA wish I could add more, I'm all in already waiting for takeoff!
0 · Reply
sharktrader386
sharktrader386 May. 7 at 10:13 AM
$IRAA $LIMN just a matter of time here. This can turn into a halt monster at any moment consider yourself lucky if you can load these cheapies
0 · Reply
mark3rd
mark3rd May. 6 at 9:16 PM
$IRAA look at RGC and NTCL That will be us. Whether it takes a day or a week or a month, it’s going to happen.
0 · Reply
Latest News on IRAA
No data available.
Chowface
Chowface May. 9 at 12:05 PM
$IRAA its the climb
0 · Reply
Chowface
Chowface May. 8 at 5:19 PM
$IRAA is this the start!???
0 · Reply
mark3rd
mark3rd May. 8 at 4:50 PM
$IRAA perking up, bids
0 · Reply
Chief_Bull_Made_Bear
Chief_Bull_Made_Bear May. 8 at 3:20 PM
$IRAA Liminatus Pharma ($LIMN) just dropped a brand-new investor intro video and barely anyone's watching yet. They're developing cutting-edge immunotherapies targeting Claudin18.2+ solid tumors, an emerging biomarker that's already drawn billion-dollar deals from major pharma players like Astellas. What makes LIMN stand out? A low float, a clean SPAC merger, and a pipeline backed by the NIH — this isn’t your average penny biotech. Why this matters: Claudin18.2 is a red-hot target in gastric & pancreatic cancers NIH collaboration gives them serious scientific credibility Trading under the radar with minimal volume = early entry potential Low float + catalyst = possible sharp upside Check out their intro video (uploaded just yesterday): 📽️ https://www.youtube.com/watch?v=36NnT_HNtl0 And pipeline breakdown: 🔗 http://liminatuspharma.com/bbs/content.php?co_id=cancer I’m waiting for a move when volume picks up.
0 · Reply
Chief_Bull_Made_Bear
Chief_Bull_Made_Bear May. 8 at 3:16 PM
$IRAA changed tickers to ($LIMN) Liminatus Pharma ($LIMN) just dropped a brand-new investor intro video and barely anyone's watching yet. They're developing cutting-edge immunotherapies targeting Claudin18.2+ solid tumors, an emerging biomarker that's already drawn billion-dollar deals from major pharma players like Astellas. What makes LIMN stand out? A low float, a clean SPAC merger, and a pipeline backed by the NIH — this isn’t your average penny biotech. Why this matters: Claudin18.2 is a red-hot target in gastric & pancreatic cancers. NIH collaboration gives them serious scientific credibility. Trading under the radar with minimal volume = early entry potential. Low float + catalyst = possible sharp upside. Check out their intro video: 📽️ https://www.youtube.com/watch?v=36NnT_HNtl0 And pipeline breakdown: 🔗 http://liminatuspharma.com/bbs/content.php?co_id=cancer I’m watching for a move when volume picks up again. $TSLA $GME $SPY $BTC
0 · Reply
Chief_Bull_Made_Bear
Chief_Bull_Made_Bear May. 8 at 3:04 PM
$IRAA Volume brings massive swings here $BTC $TRUMP.X $DOGE.X
0 · Reply
Chief_Bull_Made_Bear
Chief_Bull_Made_Bear May. 8 at 12:08 AM
$IRAA changed ticker to $LIMN The free float for LIMN (Liminatus Pharma Inc.) is 174.48K shares. This means that out of the total 7.07M shares outstanding, only 174.48K are available for public trading. The remaining shares are likely held by insiders, promoters, or other restricted parties. A smaller free float can sometimes lead to higher price volatility, as fewer shares are available for trading, Already spiked 5 to 24 / 8 to 16 just fyi do whatever you wanna do. $TSLA $GME
0 · Reply
Chowface
Chowface May. 7 at 12:20 PM
$IRAA wish I could add more, I'm all in already waiting for takeoff!
0 · Reply
sharktrader386
sharktrader386 May. 7 at 10:13 AM
$IRAA $LIMN just a matter of time here. This can turn into a halt monster at any moment consider yourself lucky if you can load these cheapies
0 · Reply
mark3rd
mark3rd May. 6 at 9:16 PM
$IRAA look at RGC and NTCL That will be us. Whether it takes a day or a week or a month, it’s going to happen.
0 · Reply
Chief_Bull_Made_Bear
Chief_Bull_Made_Bear May. 6 at 1:17 PM
$IRAA Goos morning @Stocktwits ... you would offer me paid services and even the ability to trade on your platform, yet you cannot update a ticker change after four trading days? I don't know if I want to throw my money down on an app who cannot keep current within at least one trading day. Guess I'll stick with RH.
0 · Reply
WarrantBuffet808
WarrantBuffet808 May. 6 at 5:51 AM
@Stocktwits I'd like to send you a direct message, please follow me so we can chat please change ticker symbol $IRAA
0 · Reply
mark3rd
mark3rd May. 6 at 2:09 AM
$IRAA so I see 7 million shares total and only 170k float. Anyone know when the other 6.8 million shares enter the float
2 · Reply
Kevmnry94
Kevmnry94 May. 6 at 1:10 AM
$IRAA @Stocktwits
0 · Reply
Chief_Bull_Made_Bear
Chief_Bull_Made_Bear May. 6 at 12:26 AM
$IRAA Yes, ticker change please! @StocktwitsSupportChannel @Stocktwits
0 · Reply
mark3rd
mark3rd May. 5 at 5:50 PM
$IRAA I second that
0 · Reply
WarrantBuffet808
WarrantBuffet808 May. 5 at 4:29 PM
$IRAA @Stocktwits can we get a ticker change @StocktwitsNews
0 · Reply
Chowface
Chowface May. 5 at 4:06 PM
$IRAA we just need volume and we see $20+
0 · Reply
Chowface
Chowface May. 4 at 1:49 PM
$IRAA i got my eye on this one, added big
0 · Reply
Beardedd
Beardedd May. 2 at 5:18 PM
$IRAA nice reversal here from 6s. Let's see 50
0 · Reply
Supernova_Trade
Supernova_Trade May. 2 at 1:44 PM
$IRAA send it to $2 for reversal
0 · Reply
Chief_Bull_Made_Bear
Chief_Bull_Made_Bear May. 2 at 1:15 PM
$IRAA Liminatus Pharma Inc. Cl A's public float is currently 174,478 shares. The percent of float that is short interest is 1.10%, with 1.92K shares shorted as of August 30, 2024. $SPY $QQQ $STOCKTWITS
0 · Reply